TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
LMRI

Lumexa Imaging Holdings, Inc.

Healthcare · Medical Devices

10.20$ +3.3% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns Lumexa Imaging Holdings, Inc. (LMRI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 23.0% of the shares are freely tradable; institutional investors hold 33.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 33.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 80.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 23.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 10.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 96Mio.

Largest Shareholders

Institutions

Institutions LMRI
Name Stake (%) Shares Change (%) Date
AllianceBernstein L.P. 3.10 2,980,462 -8.0 03/31/2026
Massachusetts Financial Services Company 2.43 2,334,580 +133.5 03/31/2026
HHG PLC 2.19 2,100,356 +5.4 03/31/2026
Brown Advisory Holdings Inc 1.77 1,705,077 +0.0 03/31/2026
BlackRock Inc 1.59 1,525,683 +1,425.7 03/31/2026
Amvescap Plc. 1.50 1,440,542 +0.3 03/31/2026
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 1.35 1,300,000 -13.3 03/31/2026
JPMorgan Chase & Co 1.15 1,104,507 +28.1 03/31/2026

Funds

Funds LMRI
Name Stake (%) Shares Change (%) Date
Brown Advisory Small-Cap Fdmtl Val Inv 2.32 2,225,514 +12.5 08/31/2026
MFS New Discovery Value I 1.66 1,597,271 -7.9 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?